Risk stratification after successful coronary revascularization: the lack of a role for routine exercise testing

R J Krone1, R M Hardison, B R Chaitman

  • 1Washington University School of Medicine, St Louis, Missouri, USA.

Insights

Routine exercise testing (EXT) after coronary revascularization (CR) is valuable. Patients undergoing EXT one, three, and five years post-CR had significantly lower mortality, supporting guideline evaluations.

Area of Science:

  • Cardiology
  • Clinical Exercise Physiology

Background:

  • Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines suggest routine exercise testing (EXT) within three years of successful coronary revascularization (CR) offers limited utility.
  • This study investigates the ACC/AHA guidelines using data from the Bypass Angioplasty Revascularization Investigation (BARI).

Purpose of the Study:

  • To evaluate the ACC/AHA guidelines for exercise testing (EXT) following successful coronary revascularization (CR).

Main Methods:

  • Analysis of 1,678 patients randomized to angioplasty or bypass surgery within the BARI study.
  • Patients underwent symptom-limited treadmill tests at one, three, and five years post-revascularization.

Main Results:

  • Patients who completed EXT at one, three, and five years post-CR demonstrated significantly lower subsequent two-year mortality compared to those who did not (1.9% vs. 9.4%, 3.5% vs. 12.6%, and 3.3% vs. 11.0%, respectively; p < 0.0001 for all).
  • Exercise parameters from one- and three-year tests did not enhance a multivariable survival model.
  • Achieving Bruce stage 3 or a Duke score >-6 on the five-year test independently predicted two-year survival.
  • ST depression on the one-year test correlated with increased revascularization events (RR = 1.6; p < 0.001).

Conclusions:

  • Patients with stable multivessel coronary disease who adhered to a protocol-mandated EXT schedule post-CR experienced low subsequent mortality.
  • Exercise parameters did not improve mortality prediction at one or three years post-CR.
  • These findings support the ACC/AHA guidelines regarding the limited value of routine EXT in stable patients within three years of CR.
Abstract

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...